ITEM 1. FINANCIAL STATEMENTS
JUBILANT FLAME INTERNATIONAL, LTD.
FOR THE THREE-MONTH PERIODS ENDED NOVEMBER 30, 2019
Index to Unaudited Financial Statements
JUBILANT FLAME INTERNATIONAL, LTD
|
Balance Sheets
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
November 30,
|
|
|
February 28,
|
|
|
|
2019
|
|
|
2019
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
Cash
|
|
$
|
7,124
|
|
|
$
|
12,115
|
|
Accounts receivable
|
|
|
13,171
|
|
|
|
279
|
|
Inventory
|
|
|
25
|
|
|
|
7,293
|
|
Prepaid expenses
|
|
|
12,000
|
|
|
|
9,000
|
|
Total current assets
|
|
|
32,320
|
|
|
|
28,687
|
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$
|
32,320
|
|
|
$
|
28,687
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES & STOCKHOLDERS’ DEFICIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
Accounts payable and accrued liabilities
|
|
$
|
377
|
|
|
$
|
42,011
|
|
Due to related party
|
|
|
57,763
|
|
|
|
2,178
|
|
Accrued officer compensation
|
|
|
535,500
|
|
|
|
535,500
|
|
Loan payable - related parties
|
|
|
473,372
|
|
|
|
443,606
|
|
Total current liabilities
|
|
|
1,067,012
|
|
|
|
1,023,295
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
1,067,012
|
|
|
|
1,023,295
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ Deficit
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value per share 75,000,000 shares authorized; 18,923,208 and 18,548,208 shares issued and outstanding at November 30, 2019 and February 28, 2019, respectively
|
|
|
18,924
|
|
|
|
18,548
|
|
Additional paid in capital
|
|
|
2,431,858
|
|
|
|
2,418,733
|
|
Accumulated deficit
|
|
|
(3,485,474
|
)
|
|
|
(3,431,889
|
)
|
Total Stockholders’ Deficit
|
|
|
(1,034,692
|
)
|
|
|
(994,608
|
)
|
Total Liabilities and Stockholders’ Deficit
|
|
$
|
32,320
|
|
|
$
|
28,687
|
|
The accompanying notes are an integral part of these financial statements.
JUBILANT FLAME INTERNATIONAL, LTD
|
Statements of Operations
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended
|
|
|
For the nine months ended
|
|
|
|
November 30,
|
|
|
November 30,
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales of goods
|
|
$
|
20,434
|
|
|
$
|
24,099
|
|
|
$
|
36,949
|
|
|
|
38,190
|
|
Total revenue
|
|
|
20,434
|
|
|
|
24,099
|
|
|
|
36,949
|
|
|
|
38,190
|
|
Costs and Operating Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
|
5,209
|
|
|
|
16,856
|
|
|
|
12,760
|
|
|
|
24,342
|
|
Operating, selling, general and administrative
|
|
|
25,665
|
|
|
|
101,458
|
|
|
$
|
77,774
|
|
|
$
|
311,084
|
|
Total operating expenses
|
|
|
30,874
|
|
|
|
118,314
|
|
|
|
90,534
|
|
|
|
335,426
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income(loss) from operations
|
|
|
(10,440
|
)
|
|
|
(94,215
|
)
|
|
|
(53,585
|
)
|
|
|
(297,236
|
)
|
Other income (expense) net
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Income (loss) before provision for income taxes
|
|
|
(10,440
|
)
|
|
|
(94,215
|
)
|
|
|
(53,585
|
)
|
|
|
(297,236
|
)
|
Net income (loss)
|
|
$
|
(10,440
|
)
|
|
$
|
(94,215
|
)
|
|
$
|
(53,585
|
)
|
|
$
|
(297,236
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Basic and fully diluted)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.01
|
)
|
|
$
|
(0.00
|
)
|
|
$
|
(0.02
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares outstanding
|
|
|
18,799,582
|
|
|
|
18,460,983
|
|
|
|
18,674,117
|
|
|
|
18,435,890
|
|
The accompanying notes are an integral part of these financial statements
JUBILANT FLAME INTERNATIONAL, LTD
Statements of Changes in Stockholders’ Deficit
(Unaudited)
|
|
|
|
|
Additional
|
|
|
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
|
paid in
|
|
|
|
Accumulated
|
|
|
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
capital
|
|
|
deficit
|
|
|
Deficit
|
|
Balances at February 28, 2019
|
|
|
18,548,208
|
|
|
$
|
18,549
|
|
|
$
|
2,418,733
|
|
|
$
|
(3,431,889
|
)
|
|
$
|
(994,608
|
)
|
Shares issued for stock compensation
|
|
|
125,000
|
|
|
|
125
|
|
|
|
4,375
|
|
|
|
|
|
|
|
4,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(25,742
|
)
|
|
|
(25,742
|
)
|
Balances at May 31, 2019
|
|
|
18,673,208
|
|
|
$
|
18,674
|
|
|
$
|
2,423,108
|
|
|
$
|
(3,457,631
|
)
|
|
$
|
(1,015,850
|
)
|
Shares issued for stock compensation
|
|
|
125,000
|
|
|
|
125
|
|
|
|
4,375
|
|
|
|
|
|
|
|
4,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17,402
|
)
|
|
|
(17,402
|
)
|
Balances at August 31, 2019
|
|
|
18,798,208
|
|
|
$
|
18,799
|
|
|
$
|
2,427,483
|
|
|
$
|
(3,475,033
|
)
|
|
$
|
(1,028,752
|
)
|
Shares issued for stock compensation
|
|
|
125,000
|
|
|
|
125
|
|
|
|
4,375
|
|
|
|
|
|
|
|
4,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,440
|
)
|
|
|
(10,440
|
)
|
Balances at November 30, 2019
|
|
|
18,923,208
|
|
|
$
|
18,924
|
|
|
$
|
2,431,858
|
|
|
$
|
(3,485,473
|
)
|
|
$
|
(1,034,692
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
|
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
|
paid in
|
|
|
|
Accumulated
|
|
|
|
Stockholders’
|
|
|
|
Shares
|
|
|
Amount
|
|
|
capital
|
|
|
deficit
|
|
|
Deficit
|
|
Balances at February 28, 2018
|
|
|
18,410,708
|
|
|
$
|
18,411
|
|
|
$
|
2,259,120
|
|
|
$
|
(3,115,790
|
)
|
|
$
|
(838,259
|
)
|
Shares issued for stock compensation
|
|
|
25,000
|
|
|
|
25
|
|
|
|
52,475
|
|
|
|
|
|
|
|
52,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(109,635
|
)
|
|
|
(109,635
|
)
|
Balances at May 31, 2018
|
|
|
18,435,708
|
|
|
$
|
18,436
|
|
|
$
|
2,311,595
|
|
|
$
|
(3,225,425
|
)
|
|
$
|
(895,394
|
)
|
Shares issued for stock compensation
|
|
|
25,000
|
|
|
|
25
|
|
|
|
52,475
|
|
|
|
|
|
|
|
52,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(93,386
|
)
|
|
|
(93,386
|
)
|
Balances at August 31, 2018
|
|
|
18,460,708
|
|
|
$
|
18,461
|
|
|
$
|
2,364,070
|
|
|
$
|
(3,318,811
|
)
|
|
$
|
(936,280
|
)
|
Shares issued for stock compensation
|
|
|
25,000
|
|
|
|
25
|
|
|
|
52,475
|
|
|
|
|
|
|
|
52,500
|
|
Net loss for the period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(94,215
|
)
|
|
|
(94,215
|
)
|
Balances at November 30, 2018
|
|
|
18,485,708
|
|
|
$
|
18,486
|
|
|
$
|
2,416,545
|
|
|
$
|
(3,413,026
|
)
|
|
$
|
(977,995
|
)
|
The accompanying notes are an integral part of these financial statements
JUBILANT FLAME INTERNATIONAL, LTD
|
|
Statements of Cash Flows
|
|
(Unaudited)
|
|
|
|
For the nine months
ended November 30,
|
|
|
|
2019
|
|
|
2018
|
|
Cash Flows from Operating Activities:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(53,585
|
)
|
|
$
|
(297,236
|
)
|
|
|
|
|
|
|
|
|
|
Adjustments to reconcile net (loss) to net cash (used in) operating activities
|
|
|
|
|
|
|
|
|
Website amortization
|
|
|
-
|
|
|
|
3,473
|
|
Share based compensation
|
|
|
13,501
|
|
|
|
157,500
|
|
Changes in Current Assets and Liabilities:
|
|
|
|
|
|
|
|
|
Account receivable
|
|
|
(12,892
|
)
|
|
|
(2,370
|
)
|
Inventory
|
|
|
7,268
|
|
|
|
(3,880
|
)
|
Prepaid expense
|
|
|
(3,000
|
)
|
|
|
(4,500
|
)
|
Accounts payable
|
|
|
(41,947
|
)
|
|
|
3,170
|
|
Due to related party
|
|
|
55,898
|
|
|
|
28,993
|
|
Accrued officer’s compensation
|
|
|
-
|
|
|
|
75,375
|
|
Net cash used in operating activities
|
|
|
(34,757
|
)
|
|
|
(39,475
|
)
|
Cash Flows from Financing Activities:
|
|
|
|
|
|
|
|
|
Net proceeds from related party loans
|
|
|
29,766
|
|
|
|
47,321
|
|
Net cash provided by financing activities
|
|
|
29,766
|
|
|
|
47,321
|
|
Net (Decrease) In Cash
|
|
|
(4,991
|
)
|
|
|
7,846
|
|
Cash at The Beginning Of The Period
|
|
|
12,115
|
|
|
|
8,036
|
|
Cash at The End Of The Period
|
|
$
|
7,124
|
|
|
$
|
15,882
|
|
The accompanying notes are an integral part of these financial statements
JUBILANT FLAME INTERNATIONAL, LTD
Notes to Financial Statements
November 30, 2019
(Unaudited)
NOTE 1 – ORGANIZATION AND OPERATIONS
Jubilant Flame International, Ltd. (the “Company”), was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012 the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On August 18, 2015, the Company changed its name to Jubilant Flame International, Ltd.
From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States.
From the third quarter of the fiscal year ended February 28, 2020, the company started to provide technical service to customer to develop nutrition beverage series products to sell in the USA market. Currently the nutrition beverage series include SEA-BUCKTHORN and Organic Sprouting Powder.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
Interim Financial Information
Interim financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) as promulgated in Item 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of November 30, 2019, results of operations, changes in stockholders’ equity (deficit) and cash flows for the three month periods ended November 30, 2019 and 2018, as applicable, have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company’s Form 10-K.
Use of Estimates and Assumptions
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
The Company’s significant estimates include income tax provisions and valuation allowances of deferred tax assets; the fair value of financial instruments and the assumption that the company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.
Recent Accounting Pronouncements
Pronouncements Adopted in Fiscal 2018
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company adopts this ASU from the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU resulted in no adjustment to retained earnings and current financial statements.
Net Loss Per Common Share
Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period.
NOTE 3 – GOING CONCERN
The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As of November 30, 2019 ,the Company had current assets of $32,320, and current liabilities total $1,067,012 resulting in a working capital deficit of $1,034,692. The Company currently has small scale trading activities and has an accumulated deficit of $3,485,474 as of November 30, 2019. This raises substantial doubt about the Company’s ability to continue as a going concern.
The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetics and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.
NOTE 4 – PREPAID EXPENSE
The Company is paying an annual fee for its OTC Markets service. The service period is from December 1, 2019 to November 30, 2020. The service charge is recorded as a prepaid expense and amortized using straight line amortization over the service period. The prepaid expense balance is $12,000 as of November 30, 2019 compared to $9,000 as of February 28, 2019.
NOTE 5 – RELATED PARTY TRANSACTIONS
In support of the Company’s efforts and cash requirements, it must rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its common stock or traditional debt financing. There is no formal written commitment for continued support by shareholders. The advances are considered temporary in nature and have not been formalized by a promissory note.
As of November 30, 2019, the Company had a $473,372 loan outstanding with its CEO, Ms. Yan Li. This compares with the outstanding balance of $443,606 for Ms. Yan Li at February 28, 2019. The loans are non-interest bearing, due upon demand and unsecured.
A related party is providing accounting service to the company at an estimated annual service fee of $23,000. From November 2017, the Company started to purchase products from a related party controlled by our CEO. As of the nine-month period ended November 30, 2019, the Company incurred a total of $57,763 due to related party for inventory purchase and accrued service fee. This compares with a total of $2,178 due to related party for inventory purchase and accrued service fee at February 28, 2019.
NOTE 6 – ACCRUED OFFICER COMPENSATION AND STOCK COMPENSATION
On December 15, 2015, the Company entered into employment agreements with its president, Ms. Yan Li, and its former secretary and treasurer, Mr. Robert Ireland. Both agreements were retroactively effective as of December 4, 2015, for a term of 36 months (measured from December 4, 2015). On August 30, 2017, Mr. Robert Ireland resigned as Secretary/Treasurer of the company.
On January 15, 2019, the board of the company approved new compensation to its five officers including two new appointed directors. The five directors waived their salary and receives total 500,000 shares each year for a term of three years.
As of November 30, 2019, a total of $535,500 had been accrued as salary compensation payable compared to $535,500 at February 28, 2019 to the president only.
During the three months ended November 30, 2019, a total of $4,500 stock compensation had been recorded to the five senior officers compared to $52,500 for the same period in the prior year to the president.
NOTE 7 – STOCKHOLDERS’ EQUITY
For the nine months ended November 30, 2019, a total of 375,000 Shares were issued to the president and other four senior officers as stock compensation. Total value of $13,500 has been recorded for the stock compensation.
NOTE 8 – SUBSEQUENT EVENTS
None.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.
Our Business
Jubilant Flame International, Ltd., (the “Company”, “the “Registrant”, “we”, “us” or “our”) was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from “LBYV” to “JFIL.” On July 24, 2013, the Company changed its business sector to the medical sector. On August 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.
From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States. From the third quarter of the fiscal year ended February 28, 2020, the company started to provide technical service to third party companies to develop nutrition beverage series products to sell in the USA market. Currently the nutrition beverage series include SEA-BUCKTHORN and Organic Sprouting Powder.
The Company has the right to develop and market medical products under a license from BioMark. The primary intended products include Bone-Induction Artificial Bone (“BIAB”) and Vacuum Sealing Drainage (“VSD”) but the Company currently does not have any plan to deploy such licenses and is focusing its operation on the Acropass products.
Results of Operations
Revenue
We recognized $20,434 sales revenue in the three months and $36,949 in nine months ended November 30, 2019 compared to $24,099 sales revenue in the three months and $38,190 sales revenue in the nine months ended November 30, 2018.
Operating Expenses
For the three months ended November 30, 2019 compared to the three months ended November 30, 2018
The major components of our operating expenses for the three months ended November 30, 2019 and 2018 are outlined in the table below:
|
|
Three Months
Ended
|
|
|
Three Months
Ended
|
|
|
|
November 30,
2019
|
|
|
November 30,
2018
|
|
|
|
|
|
|
|
|
Officer compensation
|
|
$
|
4,500
|
|
|
$
|
77,625
|
|
Selling expense
|
|
$
|
4,753
|
|
|
$
|
10,898
|
|
Professional fee
|
|
$
|
12,325
|
|
|
$
|
10,367
|
|
OTC Filing fees
|
|
$
|
3,000
|
|
|
$
|
2,500
|
|
Office expense
|
|
$
|
1,087
|
|
|
$
|
69
|
|
Total operating expenses
|
|
$
|
25,665
|
|
|
$
|
101,459
|
|
The $75,794 decrease in our operating costs for the three months ended November 30, 2019 compared to three months ended November 30, 2018, was mainly due to a decrease of $73,125 in officer salary compensation as a result of waiving of officer salary since January, 2019, and reduction in stock compensation to officers.
For the nine months ended November 30, 2019 compared to the nine months ended November 30, 2018
The major components of our operating expenses for the nine months ended November 30, 2019 and 2018 are outlined in the table below:
|
|
Nine Months
Ended
|
|
|
Nine Months
Ended
|
|
|
|
November 30,
2019
|
|
|
November 30,
2019
|
|
|
|
|
|
|
|
|
Officer compensation
|
|
$
|
13,500
|
|
|
$
|
232,875
|
|
Selling expense
|
|
$
|
11,414
|
|
|
$
|
24,395
|
|
Transfer agent
|
|
$
|
5,000
|
|
|
$
|
5,000
|
|
Edgar filing fees
|
|
$
|
2,184
|
|
|
$
|
2,184
|
|
Accounting & Audit fees
|
|
$
|
32,850
|
|
|
$
|
31,500
|
|
OTC Filing fees
|
|
$
|
9,000
|
|
|
$
|
7,500
|
|
Office expense
|
|
$
|
2,278
|
|
|
$
|
1,418
|
|
Web Amortization expense
|
|
$
|
-
|
|
|
$
|
3,473
|
|
Legal fees
|
|
$
|
1,548
|
|
|
$
|
2,739
|
|
Total operating expenses
|
|
$
|
77,774
|
|
|
$
|
311,084
|
|
The $233,310 decrease in our operating costs for the nine months ended November 30, 2019 compared to nine months ended November 30, 2018, was mainly due to a decrease of $219,375 in officer salary compensation as a result of waiving of officer salary since January, 2019, and reduction in stock compensation to officers, and a decrease of $12,981 in selling expense due to new product campaign and promotion activity reduction.
Other Expenses
No other expense during the period of three months and nine months ended November 30, 2019 and 2018.
Net Loss
For the three months ended November 30, 2019, we recognized a net loss of $10,440 compared to the net loss of $94,215 for the corresponding period in 2018.
For the nine months ended November 30, 2019, we recognized a net loss of $53,585 compared to the net loss of $297,236 for the corresponding period in 2018.
Liquidity and Capital Resources
Working Capital
|
|
November 30,
2019
|
|
|
February 28,
2019
|
|
Current Assets
|
|
$
|
32,320
|
|
|
$
|
28,687
|
|
Current Liabilities
|
|
$
|
1,067,012
|
|
|
$
|
1,023,295
|
|
Working Capital Deficit
|
|
$
|
(1,034,692
|
)
|
|
$
|
(994,608
|
)
|
As of November 30, 2019, the Company had current assets of $32,320, primarily comprising of cash of $7,124, inventory of $25 and prepaid expense of $12,000, and current liabilities of $1,067,012, resulting in a working capital deficit of $1,034,692. The Company had limited profitable trading activities and has an accumulated deficit of $3,485,474 as at November 30, 2019. This raises substantial doubt about the Company’s ability to continue as a going concern.
The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.
Based on the Company’s current operating plan, the Company does not have sufficient cash and cash equivalents to fund its operations for at least the next twelve months. The Company will need to obtain additional financing to operate our business. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetic and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.
Cash Flows from Operating Activities
Our net cash used in operating activities decreased by $4,718 in the nine months ended November 30, 2019 compared to the net cash used in operating activities in the nine months ended November 30, 2018, representing a decrease of 11.9%. The decrease in net cash used in operating activities was primarily the result of a $12,981 decrease in selling expense .
Cash Flows from Investing Activities
We did not generate or use any cash from investing activities during the nine months ended November 30, 2019 or 2018.
Cash Flows from Financing Activities
Our cash provided by financing activities decreased from $47,321 for the nine months ended November 30, 2018 to $29,766 for the nine months ended November 30, 2019. In both periods, cash was provided by way of loans from related parties.
Future Financings
We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.
Recent Accounting Pronouncements
Pronouncements Adopted in Fiscal 2018
In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company adopts this ASU for the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU resulted in no adjustment to retained earnings and current financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). Under this guidance, lessees will be required to recognize on the balance sheet a lease liability and a right-of-use asset for all leases, with the exception of short-term leases. The lease liability represents the lessee’s obligation to make lease payments arising from a lease, and will be measured as the present value of the lease payments. The right-of-use asset represents the lessee’s right to use a specified asset for the lease term, and will be measured at the lease liability amount, adjusted for lease prepayment, lease incentives received and the lessee’s initial direct costs. The standard also requires a lessee to recognize a single lease cost allocated over the lease term, generally on a straight-line basis. The new guidance is effective for fiscal years beginning after December 15, 2018. ASU 2016-02 is required to be applied using the modified retrospective approach for all leases existing as of the effective date and provides for certain practical expedients. Early adoption is permitted. The Company adopts this ASU on January 1, 2019. There is no effects that the adoption of ASU 2016-02 will have on the Company’s financial statements.
Off Balance Sheet Arrangements
As of November 30, 2019, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.